ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 48 for:    Recruiting, Not yet recruiting, Available Studies | "Hospice Care"

Research Into the Quality of the Dying Phase

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02822690
Recruitment Status : Recruiting
First Posted : July 4, 2016
Last Update Posted : October 12, 2018
Sponsor:
Collaborator:
Martini Hospital Groningen
Information provided by (Responsible Party):
A.K.L. Reyners, University Medical Center Groningen

June 24, 2016
July 4, 2016
October 12, 2018
October 2016
June 2019   (Final data collection date for primary outcome measure)
Quality of life questionnaire [ Time Frame: 2 years ]
Quality of life questionnnaire [ Time Frame: 2 years ]
Complete list of historical versions of study NCT02822690 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Research Into the Quality of the Dying Phase
Research Into the Quality of the Dying Phase in Hospitals in the Province of Groningen

The aim of this study is to get insight in the quality of life at the end of life and quality of dying for patients died at the hospital in the department Groningen (the Netherlands).

The primary endpoint is the quality of life at the end of life and the secondary endpoint is the quality of dying. Both according a numerical rating scale.

An explorative analysis will be done for differences for the hospitals in Groningen, effect of using the Liverpool care Pathway for the dying, effect of using consultation by the palliative consultation team, effect of using the Hospice@UMCG intervention, correlation with the quality of life at the end of life and quality of dying according to nurses and doctors.

Three hospitals in the department Groningen (the Netherlands) will participate in this study. When a patient died in one of these hospitals (except the emergency department, child ward and intensive care unit) the bereaved relatives will get an information letter. After about 12 weeks a questionnaire will be sent to the bereaved relative. This questionnaire is developed to evaluate the end of life care at the hospital.

Shortly after the patient died at the hospital, also the nurse and doctor of this patient are requested to fill out a questionnaire.

The questionnaire for the bereaved relatives consists of items, divided in groups: a general part, followed by questions of the last days of life, existing symptoms (physical, psychological, existential and social), the care and treatment and the loss.

The questionnaire for the nurses exists of similar items. Special attention for recognizing the impending dying and problems, care and therapy at the end of life.

In all questionnaires there are also 2 main questions: What is your opinion of the quality of life during the last days of life and What is your opinion of the quality of dying.

In the three hospitals the end of life care is managed at somehow different ways: the use of the Liverpool care Pathway of the dying, the hospice@UMCG intervention and consultation by the palliative team of the hospital.

Observational
Observational Model: Family-Based
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
all patients dying in the hospital
Cessation of Life
Other: Hospice care at UMCG
introduction of hospice care facilities on the wards at the UMCG
  • University Medical Center Groningen
    all patients that died on one of the wards with the exception of children; on several wards the Hospice care will be introduced as an intervention
    Intervention: Other: Hospice care at UMCG
  • Martini Ziekenhuis
    all patients that died on one of the wards with the exception of children
  • Ommelander ZorgGroep
    all patients that died on one of the wards with the exception of children
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
200
Same as current
June 2019
June 2019   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • patients dying in the hospital

Exclusion Criteria:

  • patients dying at the child ward, emergency dept. and intensive care dept.
Sexes Eligible for Study: All
18 Years and older   (Adult, Older Adult)
No
Contact: Annette WG van der Velden, MD 050-3616161 ext 0770 a.w.g.van.der.velden@umcg.nl
Contact: An KL Reyners, MD/PhD 050-3616161 ext 0770 a.k.l.reyners@umcg.nl
Netherlands
 
 
NCT02822690
2016pz/1
No
Not Provided
Plan to Share IPD: No
A.K.L. Reyners, University Medical Center Groningen
University Medical Center Groningen
Martini Hospital Groningen
Principal Investigator: An KL Reyners, MD/PhD UMCG
University Medical Center Groningen
October 2018